tetradecanoylphorbol acetate has been researched along with alprazolam in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castle, SC; Chang, MP; Norman, DC | 1 |
| Gardner, CR; Laskin, DL; Laskin, JD | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and alprazolam
| Article | Year |
|---|---|
Mechanism of immunosuppressive effect of alprazolam: alprazolam suppresses T-cell proliferation by selectively inhibiting the production of IL2 but not acquisition of IL2 receptor.
Topics: Alprazolam; Animals; Concanavalin A; Immunosuppressive Agents; Interleukin-2; Ionomycin; Lymphocyte Activation; Male; Mice; Mice, Inbred BALB C; Receptors, Interleukin-2; T-Lymphocytes; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 1992 |
Platelet-activating factor-induced calcium mobilization and oxidative metabolism in hepatic macrophages and endothelial cells.
Topics: Alprazolam; Animals; Calcium; Cells, Cultured; Endothelium; Female; Kinetics; Kupffer Cells; Liver; Oxygen Consumption; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Superoxides; Tetradecanoylphorbol Acetate; Triazolam; Verapamil | 1993 |